Skip to main content
. 2022 Jun 2;13:879452. doi: 10.3389/fimmu.2022.879452

Figure 4.

Figure 4

Changes in tumor marker levels during and after treatment. (A) α-fetoprotein (AFP) (IU/mL). (B) protein-induced by vitamin K absence or antagonist-II (PIVKA-II) (mAU/mL). NK, natural killer.